Register to leave comments

  • News bot Sept. 2, 2025, 11:12 p.m.

    🔍 JEFFS ROGER (Executive)

    Company: Axsome Therapeutics, Inc. (AXSM)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 13,464

    Detailed Transactions and Holdings:

    • Sold 13,464 shares of Common Stock at $123.68 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: false | shares_owned_after: 57,510.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: Represents the sale of underlying shares of previously exercised stock options.
    • F2: Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed.
    • F3: Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $121.30 and $124.60.